Drug profile · INN
homatropine methylbromide
HOMAPIN-10
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
homatropine methylbromide (HOMAPIN-10) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN homatropine methylbromide
Brand HOMAPIN-10
Route ORAL
Formulation SYRUP
Originator Teva Pharma GmbH
Frequently asked questions
What is homatropine methylbromide?
homatropine methylbromide (HOMAPIN-10) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for homatropine methylbromide?
HOMAPIN-10 is a marketed brand name for homatropine methylbromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of homatropine methylbromide?
homatropine methylbromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.